Q3FY17 Results:Alkem Laboratories Ltd
Bhagyashree Vivarekar / 10 Feb 2017
The company reported PAT of Rs 236.2 crore, which represents a sequential QoQ decline of 18.01 per cent and a YoY increase of 24.19 per cent.
Alkem Laboratories Ltd. reported its consolidated results for the quarter ended December 31, 2016 today.
The company reported sales of Rs 1482 crore for Q3FY17, which represents a 9.52 per cent sequential decline and 15.06 per cent YoY increase.
Its operating profit (EBIT) for the quarter was Rs 242 crore and its EBIT margin was 16.33 per cent.
The company reported PAT of Rs 236.2 crore, which represents a sequential QoQ decline of 18.01 per cent and a YoY increase of 24.19 per cent.
Alkem Laboratories Ltd is an Indian company engaged in manufacturing, buying, selling and dealing in pharmaceuticals, cosmetics, beauty-aids, oils and surgical equipments. The company has its registered office in Mumbai.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.